Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2014, Vol. 34 Issue (2): 104-108    DOI: 10.13523/j.cb.20140217
    
Research Progress in Circulating MicroRNAs of Body Fluid
MAN Chao-lai1, YANG Mei-ling2
1. Key Laboratory of Molecular Cytogenetics and Genetic Breeding of Heilongjiang Province, College of Life Science and Technology, Harbin Normal University, Harbin 150025, China;
2. College of Life Science and Technology, Harbin Institute of Technology, Harbin 150025, China
Download: HTML   PDF(374KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Circulating microRNAs (miRNAs) are a family of important small non-coding RNA molecules, which participate in communication between different cells. Because circulating miRNA can be used as biomarkers of many diseases, it has attracted more attention recently. The sources and existence forms of circulating miRNAs were briefly summarized, sample preparation and detection methods of circulating miRNAs were analyzed. Additionally, the applications of circulating miRNAs were also discussed. It can provide references for further study and use of miRNAs in theory and practice fields.



Key wordsCirculating microRNAs      Detection      Immune      Tumor     
Received: 05 August 2013      Published: 25 February 2014
ZTFLH:  Q752  
Cite this article:

MAN Chao-lai, YANG Mei-ling. Research Progress in Circulating MicroRNAs of Body Fluid. China Biotechnology, 2014, 34(2): 104-108.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140217     OR     https://manu60.magtech.com.cn/biotech/Y2014/V34/I2/104

[1] Coulouarn C, Factor V M, Andersen J B, et al. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene, 2009, 28(40): 3526-3536.
[2] Wang G K, Zhu J Q, Zhang J T, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J, 2010, 31(6): 659-666.
[3] Iguchi H, Kosaka N, Ochiya T. Secretory microRNAs as a versatile communication tool. Commun Integr Biol, 2010, 3(5): 478-481.
[4] Ogawa R, Tanaka C, Sato M, et al. Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun, 2010, 398(4): 723-729.
[5] Hunter M P, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One, 2008, 3(11): e3694.
[6] Taylor D D, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol, 2008, 110(1): 13-21.
[7] Skog J, Würdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol, 2008, 10(12): 1470-1476.
[8] Zhang L, Hou D, Chen X, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res, 2012, 22(1):107-126.
[9] Orozco A F, Lewis D E. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A, 2010, 77(6): 502-514.
[10] Février B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol, 2004,16(4): 415-421.
[11] Zomer A, Vendrig T, Hopmans E S, et al. Exosomes: Fit to deliver small RNA. Commun Integr Biol, 2010, 3(5): 447-450.
[12] Simpson R J, Lim J W, Moritz R L, et al. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics, 2009, 6(3): 267-283.
[13] Arroyo J D, Chevillet J R, Kroh E M, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A, 2011, 108(12): 5003-5008.
[14] Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res, 2011, 39(16): 7223-7233.
[15] Vickers K C, Palmisano B T, Shoucri B M, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol, 2011, 13(4): 423-433.
[16] Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res, 2010, 38(20): 7248-7259.
[17] Kroh E M, Parkin R K, Mitchell P S, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods, 2010, 50(4): 298-301.
[18] Hanson E K, Ballantyne J. Circulating microRNA for the identification of forensically relevant body fluids. Methods Mol Biol, 2013, 1024: 221-234.
[19] He S, Chu J, Wu L C, et al. MicroRNAs activate natural killer cells through Toll-like receptor signaling. Blood, 2013, 121(23): 4663-4671.
[20] Fabbri M, Paone A, Calore F, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A, 2012, 109(31): E2110-2116.
[21] Miao C G, Yang Y Y, He X, et al. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus. Cell Signal, 2013, 25(9):1828-1836.
[22] Fichtlscherer S, Zeiher A M, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol, 2011, 31(11): 2383-2390.
[23] Mo M H, Chen L, Fu Y, et al. Cell-free circulating miRNA biomarkers in cancer. J Cancer, 2012, 3: 432-448.
[24] Allegra A, Alonci A, Campo S, et al. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer. Int J Oncol, 2012, 41(6):1897-1912.
[25] van Empel V P, De Windt L J, da Costa Martins P A. Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr Hypertens Rep, 2012, 14(6): 498-509.
[26] Tijsen A J, Pinto Y M, Creemers E E. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol, 2012, 303(9):1085-1095.
[27] Creemers E E, Tijsen A J, Pinto Y M. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res, 2012, 110(3): 483-495.
[28] Weber J A, Baxter D H, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem, 2010, 56(11): 1733-1741.
[29] Kosaka N, Izumi H, Sekine K, et al. microRNA as a new immune-regulatory agent in breast milk. Silence, 2010,1(1): 7.
[30] Igaz P, Nagy Z, Vásárhelyi B, et al. Potential role for microRNAs in inter-individual and inter-species communication. Orv Hetil, 2012, 153(42):1647-1650.

[1] ZHAO Meng-ze,LI Feng-zhi,WANG Peng-yin,LI Jian,XU Han-mei. Research Progress of Dual-target Blocking Therapy of PD-L1 and VEGF[J]. China Biotechnology, 2021, 41(9): 71-77.
[2] MA Qiao-ni,WANG Meng,ZHU Xing-quan. Research Advances in Recombinase-aided Amplification Technology and Its Application in Rapid Detection of Pathogenic Microorganisms[J]. China Biotechnology, 2021, 41(6): 45-49.
[3] LV Hui-zhong,ZHAO Chen-chen,ZHU Lian,XU Na. Progress of Using Exosome for Drug Targeted Delivery in Tumor Therapy[J]. China Biotechnology, 2021, 41(5): 79-86.
[4] LI Shuai-peng,REN He,AN Zhan-fei,YANG Yan-kun,BAI Zhong-hu. The Development of Chemiluminescence Immunoassay Detection Method for Thrombomodulin[J]. China Biotechnology, 2021, 41(4): 30-36.
[5] ZHANG Xue-jie,TANG Jia-bao,LI Ting-dong,GE Sheng-xiang. Advances in Single Molecule Immunoassay[J]. China Biotechnology, 2021, 41(4): 47-54.
[6] ZHOU Zi-hui,LIU Xiao-xian,HUANG Hao,XIAO Rui,QI Ke-zong,WANG Sheng-qi. Application of Surface-enhanced Raman Scattering Based onNano-signal Tags in Pathogen Detection[J]. China Biotechnology, 2021, 41(2/3): 70-77.
[7] YUAN Bo,WANG Jie-wen,KANG Guang-bo,HUANG He. Research Progress and Application of Bispecific Nanobody[J]. China Biotechnology, 2021, 41(2/3): 78-88.
[8] DENG Rui,ZENG Jia-li,LU Xue-mei. Screening and Structure-activity Relationship Analysis of Anti-tumor Derived Peptides Based on Musca domestica cecropin[J]. China Biotechnology, 2021, 41(11): 14-22.
[9] ZHANG Zheng-yan,CHEN Yu,SONG Li-jie,SU Zheng-quan,ZHANG Hai-yan. Advances in the Application of Field Effect Transistor Biosensor in Biomedical Detection[J]. China Biotechnology, 2021, 41(10): 73-88.
[10] LIN Shi-xin,LIU Dong-chen,LEI Yun,XIONG Sheng,XIE Qiu-ling. Screening, Expression and Specificity Detection of Anti-TNF-α Nanobody[J]. China Biotechnology, 2020, 40(7): 15-21.
[11] CHENG Xu,YANG Yu-qing,WU Sai-nan,HOU Qin-long,LI Yong-mei,HAN Hui-ming. Construction of DNA Vaccines of Staphylococcus aureus SarA, IcaA and Their Fusion Genes and Preliminary Study in Mouse Immune Response[J]. China Biotechnology, 2020, 40(7): 41-50.
[12] YANG Wei,SONG Fang-xiang,WANG Shuai,ZHANG Li,WANG Hong-xia,LI Yan. Preparation and Application of Janus Nanoparticles in Drug Delivery System[J]. China Biotechnology, 2020, 40(7): 70-81.
[13] HUANG Zhao-hong,HUANG Yun-hong,HUANG Yan-mei,LONG Zhong-er,SHAN Shan. Advances in Detection and Typing of Diarrheal Escherichia coli with PCR[J]. China Biotechnology, 2020, 40(7): 82-90.
[14] ZHANG Bao-hui,XIONG Hua-long,ZHANG Tian-ying,YUAN Quan. Research Progress on Vesicular Stomatitis Virus-based Oncolytic Virotherapy[J]. China Biotechnology, 2020, 40(6): 53-62.
[15] TONG Mei,CHENG Yong-qing,LIU Jin-yi,XU Chen. Construction of a Strain for Promoting Production of Small Molecule Antibodies in Periplasmic Space of Escherichia coli[J]. China Biotechnology, 2020, 40(5): 48-56.